Celiac disease CD is a chronic autoimmune disorder of the small intestine triggered by dietary gluten in genetically predisposed individuals Advances in understanding its genetic basis immune mechanisms diagnostic tools and management strategies have markedly improved clinical outcomes This paraphrased review highlights contemporary insights into epidemiology pathogenesis diagnostic approaches clinical variants complications and novel therapeutic perspectives

celiac disease gluten-free diet HLA-DQ2/DQ8 intestinal permeability zonulin refractory celiac disease larazotide acetate IL-15 blockade

Caio, G., Volta, U., Sapone, A., Leffler, D. A., De Giorgio, R., Catassi, C., & Fasano, A. (2019). Celiac disease: An updated comprehensive review. BMC Medicine, 17(1), 142. https://doi.org/10.1186/s12916-019-1380-z

Lebwohl, B., Sanders, D. S., & Green, P. H. R. (2018). Coeliac disease. The Lancet, 391(10115), 70–81.

Catassi, C., & Fasano, A. (2022). Celiac disease. New England Journal of Medicine, 387(3), 241–250.

Fasano, A. (2020). Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer. Physiological Reviews, 100(3), 795–829.

Singh, P., Arora, A., Strand, T. A., et al. (2018). Global prevalence of celiac disease: Systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 16(6), 823–836.

Catassi, C., Gatti, S., & Fasano, A. (2014). The new epidemiology of celiac disease. Journal of Pediatric Gastroenterology and Nutrition, 59(S1), S7–S9.

Leffler, D. A., & Green, P. H. R. (2011). Clinical practice: Celiac disease. New England Journal of Medicine, 364(25), 2419–2426.

Ludvigsson, J. F., Leffler, D. A., Bai, J. C., et al. (2013). The Oslo definitions for coeliac disease and related terms. Gut, 62(1), 43–52.

Husby, S., Koletzko, S., & Korponay-Szabó, I. R. (2020). European Society Paediatric Gastroenterology Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. Journal of Pediatric Gastroenterology and Nutrition, 70(1), 141–156.

Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013). ACG clinical guidelines: Diagnosis and management of celiac disease. American Journal of Gastroenterology, 108(5), 656–676.

Sapone, A., Bai, J. C., Ciacci, C., et al. (2012). Spectrum of gluten-related disorders: Consensus on new nomenclature and classification. BMC Medicine, 10(1), 13.

Olivares, M., Walker, A. W., Capilla, A., et al. (2018). Gut microbiota trajectory in early life may predict development of celiac disease. Microbiome, 6(1), 36.

Leonard, M. M., & Fasano, A. (2019). The microbiome and celiac disease. Nature Reviews Gastroenterology & Hepatology, 16(1), 9–20.

De Palma, G., Nadal, I., Collado, M. C., & Sanz, Y. (2009). Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans. British Journal of Nutrition, 102(8), 1154–1160.

Abadie, V., Sollid, L. M., Barreiro, L. B., & Jabri, B. (2011). Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annual Review of Immunology, 29, 493–525.

Sollid, L. M., & Jabri, B. (2013). Triggers and drivers of autoimmunity: Lessons from coeliac disease. Nature Reviews Immunology, 13(4), 294–302.

Schuppan, D., & Zimmer, K. P. (2013). The diagnosis and treatment of celiac disease. Dtsch Arztebl Int, 110(49), 835–846.

Caio, G., De Giorgio, R., & Volta, U. (2018). Pathophysiology of celiac disease. International Journal of Molecular Sciences, 19(8), 2340.

Elli, L., Branchi, F., Tomba, C., et al. (2015). Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity. World Journal of Gastroenterology, 21(23), 7110–7119.

Lionetti, E., & Catassi, C. (2014). The role of environmental factors in the development of celiac disease: What is new? Pediatric Research, 75(1-2), 27–32.

Lammers, K. M., Lu, R., Brownley, J., et al. (2008). Gliadin induces an increase in intestinal permeability through the zonulin pathway. Gastroenterology, 135(1), 194–204.

Kupfer, S. S., & Jabri, B. (2012). Pathophysiology of celiac disease. Gastrointestinal Endoscopy Clinics, 22(4), 639–660.

Silvester, J. A., Graff, L. A., Rigaux, L., et al. (2016). Symptoms of celiac disease in patients on a gluten-free diet: Burden and predictors. Canadian Journal of Gastroenterology and Hepatology, 2016, 1–9.

Reilly, N. R., & Green, P. H. (2012). Epidemiology and clinical presentations of celiac disease. Seminars in Immunopathology, 34(4), 473–478.

Brown, A. C. (2021). Diet and celiac disease: Beyond gluten avoidance. Nutrients, 13(12), 4262.

Tye-Din, J. A., Galipeau, H. J., & Anderson, R. P. (2020). Celiac disease: Immunopathology and therapeutic options. Clinical Reviews in Allergy & Immunology, 59(3), 263–281.

Syage, J. A., Murray, J. A., Green, P. H., et al. (2018). Latiglutenase treatment for celiac disease: Results of a randomized controlled trial. Gastroenterology, 155(2), 421–434.

Leffler, D. A., Kelly, C. P., Abdallah, H. Z., et al. (2015). A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. American Journal of Gastroenterology, 110(6), 805–814.

Paterson, B. M., Lammers, K. M., Arrieta, M. C., Fasano, A., & Meddings, J. B. (2007). The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in celiac disease subjects: A proof of concept study. Alimentary Pharmacology & Therapeutics, 26(5), 757–766.

Kelly, C. P., Murray, J. A., Leffler, D. A., et al. (2013). TAK-101, an investigational therapy for celiac disease: Early-phase trial results. Gastroenterology, 144(5), S-137.

Ciacci, C., & Ciclitira, P. J. (2015). The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. Clinical Nutrition, 34(4), 579–583.

Aziz, I., Branchi, F., & Sanders, D. S. (2019). The rise and fall of gluten! Proceedings of the Nutrition Society, 78(2), 134–144.

Verdu, E. F., Galipeau, H. J., & Jabri, B. (2015). Novel players in coeliac disease pathogenesis: Role of the gut microbiota. Nature Reviews Gastroenterology & Hepatology, 12(9), 497–506.

Pinto-Sánchez, M. I., & Verdu, E. F. (2018). Non-celiac gluten sensitivity: Clinical relevance of immunologic and functional findings. Gastroenterology Clinics of North America, 47(1), 27–40.

Kaukinen, K., Lindfors, K., Mäki, M., & Collin, P. (2010). Advances in the treatment of celiac disease: An immunopathogenic perspective. Nature Reviews Gastroenterology & Hepatology, 7(4), 158–167.

Rubio-Tapia, A., Rahim, M. W., See, J. A., Lahr, B. D., Wu, T. T., & Murray, J. A. (2010). Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. American Journal of Gastroenterology, 105(6), 1412–1420.

Leonard, M. M., & Green, P. H. R. (2018). Clinical presentation and diagnosis of celiac disease in adults and children. Gastroenterology, 154(3), 593–608.

Kelly, C. P., & Leffler, D. A. (2020). Advances in celiac disease. Gastroenterology, 159(2), 419–431.

Malamut, G., & Cellier, C. (2014). Complications of coeliac disease. Best Practice & Research Clinical Gastroenterology, 29(3), 451–458.

Cellier, C., Delabesse, E., Helmer, C., et al. (2000). Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. The Lancet, 356(9225), 203–208.

Rintala, R. J., Mäki, M., & Kaukinen, K. (2020). Refractory celiac disease: Clinical challenges. Frontiers in Gastroenterology, 11, 220.

Caio, G., Volta, U., & De Giorgio, R. (2021). Extraintestinal manifestations of celiac disease. Digestive and Liver Disease, 53(5), 516–524.

Holmes, G. K. T. (2017). Coeliac disease and malignancy. Digestive and Liver Disease, 49(12), 1390–1396.

Pinto-Sánchez, M. I., & Smecuol, E. (2016). Risk of small-bowel carcinoma and lymphoma in celiac disease. World Journal of Gastroenterology, 22(29), 6818–6826.

Kahaly, G. J., & Frommer, L. (2018). Autoimmune polyendocrine syndromes. New England Journal of Medicine, 379(11), 1112–1121.

Stene, L. C., & Honeyman, M. C. (2006). Rotavirus infection and development of celiac disease autoimmunity. Clinical Gastroenterology and Hepatology, 4(3), 326–331.

Lionetti, E., Castellaneta, S., Francavilla, R., et al. (2014). Introduction of gluten, HLA status, and the risk of celiac disease in children. New England Journal of Medicine, 371(14), 1295–1303.

Aronsson, C. A., Lee, H. S., Liu, E., et al. (2019). Age at gluten introduction and risk of celiac disease autoimmunity: The TEDDY study. Gastroenterology, 157(4), 1037–1046.

Leonard, M. M., Karathia, H., Pujolassos, M., et al. (2021). CDGEMM study: Microbiome–metabolome interactions in early-onset celiac disease. Nature Medicine, 27(11), 2067–2077.

Fasano, A., & Catassi, C. (2012). Clinical practice: Celiac disease. New England Journal of Medicine, 367(25), 2419–2426.